Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression
白藜芦醇、碳水化合物限制与前列腺癌进展
基本信息
- 批准号:8115766
- 负责人:
- 金额:$ 30.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAndrogensAnimalsApoptosisBody WeightCarbohydratesCaringCessation of lifeClinical ResearchClinical TrialsComplementary MedicineDataDevelopmentDietDiet ModificationDietary FatsDoseEpidemiologyFat-Restricted DietFatty acid glycerol estersFoundationsFutureGoalsGrowthHumanHyperphagiaIn VitroInsulinInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IIntakeLaboratoriesMacronutrients NutritionMalignant NeoplasmsMalignant neoplasm of prostateMorbidity - disease rateMusNecrosisPhenotypePhytochemicalPlayProteinsPublic HealthReducing dietRelative (related person)Research DesignResveratrolRoleSignal TransductionSolidSomatomedinsSupplementationTestingTransgenic MiceTransgenic OrganismsUnited StatesWeightWeight GainWorkXenograft procedureandrogen independent prostate cancerbasecancer cellcancer therapycancer typefeedingimprovedin vivomenmortalitynovelpre-clinicalpreclinical studypreventred winetumortumor growthtumor progression
项目摘要
DESCRIPTION (provided by applicant):
Diet is thought to play a major role in prostate cancer development and progression, yet little is currently known. Preliminary studies from our laboratory have demonstrated that a diet completely devoid of carbohydrates can slow in vivo prostate cancer growth and appears to act via the insulin-like growth factor (IGF) axis. Recent data from others suggests that resveratrol, a natural phytochemical found in red wine, can slow tumor growth via the same mechanism. We hypothesize that the combination of carbohydrate restriction plus resveratrol , both acting via IGF-axis inhibition, can a ct together to delay prostate cancer growth. To test this hypothesis, we will pursue the following course of study: 1) determine the amount of carbohydrate restriction needed to maximally delay prostate cancer growth; 2) eucidate the role of resveratrol in delaying prostate cancer growth and determine the dose which maximally delays tumor growth; and 3) explore the combined effects of carbohydrate restriction and resveratrol supplementation relative to treatment with a Western diet. We believe these studies will better elucidate the role of carbohydrate restriction and resveratrol in modulating in vivo prostate cancer growth and will lay the solid foundation for future preclinical studies for men with prostate cancer.
PUBLIC HEALTH STATEMENT Prostate cancer is a major cause of morbidity and mortality among men in the United States. In this proposal, we aim to develop novel non-toxic complementary treatments aimed at slowing prostate cancer progression: dietary modification and phytopharmaceuticals. If these pre-clinical studies are successful, this will lay a solid foundation for future clinical studies among men with prostate cancer, which eventually stand the possibility of radically altering and improving care for men with prostate cancer.
描述(由申请人提供):
饮食被认为在前列腺癌的发展和进展中起着重要作用,但目前知之甚少。 我们实验室的初步研究表明,完全不含碳水化合物的饮食可以减缓体内前列腺癌的生长,并且似乎通过胰岛素样生长因子(IGF)轴起作用。 最近来自其他人的数据表明,白藜芦醇,一种在红葡萄酒中发现的天然植物化学物质,可以通过相同的机制减缓肿瘤生长。我们假设限制碳水化合物摄入加上白藜芦醇,两者都通过抑制IGF轴发挥作用,可以共同延缓前列腺癌的生长。为了验证这一假设,我们将进行以下研究:1)确定最大限度地延缓前列腺癌生长所需的碳水化合物限制量; 2)确定白藜芦醇在延缓前列腺癌生长中的作用,并确定最大限度地延缓肿瘤生长的剂量; 3)探索碳水化合物限制和白藜芦醇补充剂相对于西方饮食治疗的联合作用。我们相信这些研究将更好地阐明碳水化合物限制和白藜芦醇在体内调节前列腺癌生长中的作用,并将为未来前列腺癌患者的临床前研究奠定坚实的基础。
前列腺癌是美国男性发病率和死亡率的主要原因。在这项提案中,我们的目标是开发新的无毒补充治疗方法,旨在减缓前列腺癌的进展:饮食调整和植物药物。如果这些临床前研究取得成功,这将为前列腺癌患者未来的临床研究奠定坚实的基础,最终有可能从根本上改变和改善前列腺癌患者的护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Jay Freedland其他文献
Stephen Jay Freedland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Jay Freedland', 18)}}的其他基金
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
一项针对新诊断胶质母细胞瘤患者的生酮饮食与标准护理治疗相结合的随机对照 2 期研究
- 批准号:
10568656 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
KUH-ART:肾脏疾病、泌尿科和血液学高级研究培训
- 批准号:
10657816 - 财政年份:2021
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10381279 - 财政年份:2021
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
9889065 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10116314 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10376281 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
- 批准号:
10524093 - 财政年份:2018
- 资助金额:
$ 30.05万 - 项目类别:
相似海外基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
- 批准号:
10735807 - 财政年份:2023
- 资助金额:
$ 30.05万 - 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
- 批准号:
10418461 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
- 批准号:
RGPIN-2019-04999 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Discovery Grants Program - Individual
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10570208 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10688086 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
- 批准号:
10355174 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
- 批准号:
2744296 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Studentship
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
- 批准号:
10525097 - 财政年份:2022
- 资助金额:
$ 30.05万 - 项目类别: